Adam Koppel Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Adam Koppel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adam Koppel. Adam Koppel is EVP, Strategy and Bus. Dev. in BIOGEN INC. ($IDPH) and SVP, Chief Strategy Officer in BIOGEN INC. ($IDPH) and Director in PTC THERAPEUTICS, INC. ($PTCT) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in TREVENA INC ($TRVN) and Director in Aptinyx Inc. ($APTX) and Director in Solid Biosciences Inc. ($SLDB) and Director in Cerevel Therapeutics Holdings, Inc. ($ARYB).
Latest Insider Trading Transactions of Adam Koppel
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APTX, IDPH, CERE, DRNA, PTCT, SLDB, TRVN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 05 2021 | APTX | Aptinyx Inc. | Koppel Adam | Director | Option Exercise | A | 3.46 | 5,508 | 19,058 | 5,508 | |
Jan 05 2021 | APTX | Aptinyx Inc. | Koppel Adam | Director | Option Exercise | A | 3.46 | 5,508 | 19,058 | 5,508 | |
Dec 14 2020 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Sell | S | 23.40 | 1,000,000 | 23,400,000 | 3,080,237 | 4.1 M to 3.1 M (-24.51 %) |
Dec 11 2020 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Grant | A | 3.70 | 3,189,189 | 11,799,999 | 7,060,353 | 3.9 M to 7.1 M (+82.38 %) |
Nov 12 2020 | ARYB | Cerevel Therapeuti ... | Koppel Adam | Director | Buy | P | 10.30 | 332,293 | 3,422,618 | 60,632,356 | 60.3 M to 60.6 M (+0.55 %) |
Jun 18 2020 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 3.03 | 10,000 | 30,300 | 10,000 | |
Jun 18 2020 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 | |
Jun 16 2020 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Option Exercise | A | 21.61 | 15,000 | 324,150 | 15,000 | |
Jun 16 2020 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Option Exercise | A | 0.00 | 3,333 | 0 | 3,333 | |
Apr 02 2020 | APTX | Aptinyx Inc. | Koppel Adam | Director | Option Exercise | A | 2.16 | 8,296 | 17,919 | 8,296 | |
Jan 16 2020 | APTX | Aptinyx Inc. | Koppel Adam | Director | Buy | P | 3.00 | 3,333,333 | 9,999,999 | 5,558,425 | 2.2 M to 5.6 M (+149.81 %) |
Dec 06 2019 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Sell | S | 24.68 | 1,500,000 | 37,020,000 | 4,080,237 | 5.6 M to 4.1 M (-26.88 %) |
Jul 30 2019 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Grant | A | 4.65 | 1,881,720 | 8,749,998 | 3,871,164 | 2 M to 3.9 M (+94.59 %) |
Jun 21 2019 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Option Exercise | A | 15.44 | 25,000 | 386,000 | 25,000 | |
Jun 17 2019 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 5.26 | 10,000 | 52,600 | 10,000 | |
May 17 2019 | APTX | Aptinyx Inc. | Koppel Adam | Director | Option Exercise | A | 3.73 | 40,000 | 149,200 | 40,000 | |
Dec 17 2018 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 23.58 | 8,165 | 192,531 | 8,165 | |
Jul 27 2018 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 37.89 | 1,835 | 69,528 | 1,835 | |
Jun 26 2018 | APTX | Aptinyx Inc. | Koppel Adam | Director | Option Exercise | C | 0.00 | 50,347,397 | 0 | 0 | |
Jun 26 2018 | APTX | Aptinyx Inc. | Koppel Adam | Director | Buy | P | 16.00 | 400,000 | 6,400,000 | 2,225,092 | 1.8 M to 2.2 M (+21.92 %) |
Jun 26 2018 | APTX | Aptinyx Inc. | Koppel Adam | Director | Buy | C | 0.00 | 1,825,092 | 0 | 1,825,092 | 0 to 1.8 M |
Jun 26 2018 | APTX | Aptinyx Inc. | Koppel Adam | Director | Option Exercise | C | 0.00 | 50,347,397 | 0 | 0 | |
Jun 26 2018 | APTX | Aptinyx Inc. | Koppel Adam | Director | Buy | P | 16.00 | 400,000 | 6,400,000 | 2,225,092 | 1.8 M to 2.2 M (+21.92 %) |
Jun 26 2018 | APTX | Aptinyx Inc. | Koppel Adam | Director | Buy | C | 0.00 | 1,825,092 | 0 | 1,825,092 | 0 to 1.8 M |
Jun 25 2018 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Option Exercise | A | 13.08 | 25,000 | 327,000 | 25,000 | |
May 17 2018 | TRVN | TREVENA INC | Koppel Adam | Director | Option Exercise | A | 1.84 | 30,000 | 55,200 | 30,000 | |
Feb 01 2018 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | M | 0.00 | 1,991,097 | 0 | 0 | |
Feb 01 2018 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 0.00 | 1,223,240 | 0 | 1,991,097 | |
Feb 01 2018 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Buy | P | 16.00 | 300,000 | 4,800,000 | 1,989,444 | 1.7 M to 2 M (+17.76 %) |
Feb 01 2018 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Buy | M | 0.00 | 1,689,444 | 0 | 1,689,444 | 0 to 1.7 M |
Jul 20 2017 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Option Exercise | A | 3.42 | 25,000 | 85,500 | 25,000 | |
Jun 06 2017 | TRVN | TREVENA INC | Koppel Adam | Director | Option Exercise | A | 3.08 | 15,000 | 46,200 | 15,000 | |
Apr 13 2017 | DRNA | Dicerna Pharmaceut ... | Koppel Adam | Director | Option Exercise | A | 3.47 | 25,000 | 86,750 | 25,000 | |
Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Koppel Adam | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
Jun 07 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Sell | S | 290.00 | 555 | 160,950 | 2,402 | 3 K to 2.4 K (-18.77 %) |
Jun 06 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Option Exercise | J | 0.00 | 1,969 | 0 | 3,616 | |
Jun 06 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Option Exercise | M | 0.00 | 1,643 | 0 | 5,585 | |
Jun 06 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Payment of Exercise | F | 289.73 | 534 | 154,716 | 2,957 | 3.5 K to 3 K (-15.30 %) |
Jun 06 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Buy | M | 0.00 | 1,643 | 0 | 3,491 | 1.8 K to 3.5 K (+88.91 %) |
May 19 2016 | TRVN | TREVENA INC | Koppel Adam | Director | Option Exercise | A | 6.98 | 15,000 | 104,700 | 15,000 | |
Apr 07 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Sell | S | 275.00 | 102 | 28,050 | 1,848 | 2 K to 1.8 K (-5.23 %) |
Feb 25 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Option Exercise | J | 0.00 | 597 | 0 | 1,802 | |
Feb 25 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Option Exercise | M | 0.00 | 301 | 0 | 2,399 | |
Feb 25 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Payment of Exercise | F | 258.99 | 98 | 25,381 | 1,865 | 2 K to 1.9 K (-4.99 %) |
Feb 25 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Buy | M | 0.00 | 301 | 0 | 1,963 | 1.7 K to 2 K (+18.11 %) |
Feb 24 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Option Exercise | A | 0.00 | 7,270 | 0 | 7,270 | |
Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | Koppel Adam | Director | Option Exercise | A | 30.86 | 12,000 | 370,320 | 12,000 | |
Jun 04 2015 | IDPH | BIOGEN INC. | Koppel Adam | SVP, Chief Strategy ... | Option Exercise | J | 0.00 | 1,228 | 0 | 7,228 | |
Jun 04 2015 | IDPH | BIOGEN INC. | Koppel Adam | SVP, Chief Strategy ... | Option Exercise | M | 0.00 | 2,384 | 0 | 8,456 | |
Jun 04 2015 | IDPH | BIOGEN INC. | Koppel Adam | SVP, Chief Strategy ... | Payment of Exercise | F | 387.62 | 852 | 330,252 | 1,662 | 2.5 K to 1.7 K (-33.89 %) |
Jun 04 2015 | IDPH | BIOGEN INC. | Koppel Adam | SVP, Chief Strategy ... | Buy | M | 0.00 | 2,384 | 0 | 2,514 | 130 to 2.5 K (+1,833.85 %) |
May 21 2015 | TRVN | TREVENA INC | Koppel Adam | Director | Option Exercise | A | 6.80 | 8,870 | 60,316 | 8,870 | |
Feb 25 2015 | IDPH | BIOGEN INC. | Koppel Adam | SVP, Chief Strategy ... | Option Exercise | A | 0.00 | 2,700 | 0 | 2,700 | |
Jun 28 2013 | PTCT | PTC THERAPEUTICS, ... | Koppel Adam | Director | Option Exercise | C | 0.00 | 1,083,333 | 0 | 0 | |
Jun 28 2013 | PTCT | PTC THERAPEUTICS, ... | Koppel Adam | Director | Option Exercise | A | 0.00 | 1,083,333 | 0 | 1,083,333 | |
Jun 28 2013 | PTCT | PTC THERAPEUTICS, ... | Koppel Adam | Director | Buy | P | 15.00 | 1,250,000 | 18,750,000 | 2,333,333 | 1.1 M to 2.3 M (+115.38 %) |
Jun 28 2013 | PTCT | PTC THERAPEUTICS, ... | Koppel Adam | Director | Buy | C | 0.00 | 1,083,333 | 0 | 1,083,333 | 0 to 1.1 M |
Page: 1